ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE

aspirin and extended-release dipyridamole · Glenmark Pharmaceuticals Inc., USA

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE, covering 2021-04-14 to 2021-11-16. Get the full timeline:

Most recent: FDA Approved: ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)